Listar Instituto de Investigación Biomédica da Coruña (INIBIC) por autor "Aguiar, Carlos"
Mostrando ítems 1-1 de 1
-
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world
Kapelios, Chris J.; Lainscak, Mitja; Savarese, Gianluigi; Laroche, Cécile; Seferovic, Petar; Ruschitzka, Frank; Coats, Andrew; Anker, Stefan; Crespo-Leiro, María Generosa; Filippatos, Gerasimos; Piepoli, Massimo; Rosano, Giuseppe; Zanolla, Luisa; Aguiar, Carlos; Murin, Jan; Leszek, Przemyslaw; McDonagh, Theresa; Maggioni, Aldo P.; Lund, Lars H. (Wiley, 2019-05-27)[Abstract] Aims: To assess the proportion of patients with heart failure and reduced ejection fraction (HFrEF) who are eligible for sacubitril/valsartan (LCZ696) based on the European Medicines Agency/Food and Drug ...